BuSpar: Will FDA list BMY new Buspar patent ?
December 4, 2000 Bristol Myers Squibb submitted a new patent, (’365), (which it claims covers BuSpar), to the FDA for [...]
Claritin 2: Schering Plough loses Claritin Patent Protection
August 9, 2002 By GARDINER HARRIS Staff Reporter of THE WALL STREET JOURNAL A federal judge threw out Schering-Plough Corp.’s [...]
Duragesic© — JNJ likely to lose to Mylan Labs
November 21, 2003 Introduction Johnson and Johnson sued Mylan Laboratories in Burlington, Vermont in a patent infringement lawsuit involving a [...]
Levaquin®: JNJ likely to prevail against Mylan
October 18, 2002 A. Introduction and Summary The patent infringement case brought by Johnson & Johnson and Daiichi against Mylan [...]
Levaquin®: as predicted, the Court Bars Mylan’s launch
January 6, 2005 Introduction On December 23, 2004, Federal Judge Irene Keeley in Morgantown, West Virginia decided in favor of [...]
Taxol 1: Why did ABI to list 331 in the Orange Book?
April 20, 2000 Background: In April 2000, Ivax won a court order invalidating Bristol Myers Squibb’s (BMY) patent protection on [...]
Taxol 2: Can Ivax to launch its generic Taxol?
September 18, 2000 On Thursday, the Ninth Circuit refused to grant BMY’s Request for stay: if granted it would have [...]
Taxol 4: Can FDA issue ANDAs to Mylan & Zenith
April 16, 2001 Ivax’s 180 day marketing exclusivity on paclitaxel expires on April 21, 2001 On March 30, 2001, the [...]
Taxol 5: NaPro and Abbot sue Mylan
June 13, 2001 I – Introduction: The short complaint filed yesterday by NaPro and Abbot against Mylan in Federal court [...]
Related Case Type
